BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2022 12:11:23 AM | Browse: 440 | Download: 701
 |
Received |
|
2021-03-28 21:07 |
|
Peer-Review Started |
|
2021-03-28 21:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-07 02:50 |
|
Revised |
|
2021-06-15 03:08 |
|
Second Decision |
|
2021-12-06 03:31 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-12-08 06:01 |
|
Articles in Press |
|
2021-12-08 06:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-31 04:21 |
|
Publish the Manuscript Online |
|
2022-01-11 00:11 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Radiofrequency ablation in the management of primary hepatic and biliary tumors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Richard Hendriquez, Tara Keihanian, Jatinder Goyal, Rtika R Abraham, Rajnish Mishra and Mohit Girotra |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohit Girotra, FACP, MD, Associate Professor, Division of Gastroenterology and Hepatology, Swedish Medical Center, 1221 Madison Street, Set 1220, Seattle, WA 98104, United States. girotra.mohit@gmail.com |
| Key Words |
adiofrequency ablation; Radiofrequency ablation; Hepatic tumor; Biliary tumor; Cholangiocarcinoma; Hepatocellular carcinoma; Cholangiocarcinomas; Hepatocellular carcinomas |
| Core Tip |
Radiofrequency ablation (RFA) generates an area of necrosis within the targeted tissue by applying thermal therapy via an electrode, with a goal to completely eradicate the tumor while preserving surrounding healthy tissue. RFA can maintain biliary drainage by tumor ablation within the biliary ducts or occluded metallic stents, which improves survival and quality of life in unresectable cholangiocarcinomas patients. In hepatocellular carcinoma, RFA is used alone or in combination (with hepatectomy/transcatheter arterial chemoembolization) for ablation of tumors < 2 cm, and improves local tumor progression and recurrence-free survival, and considered by some to be comparative to hepatectomy. |
| Publish Date |
2022-01-11 00:11 |
| Citation |
Hendriquez R, Keihanian T, Goyal J, Abraham RR, Mishra R, Girotra M. Radiofrequency ablation in the management of primary hepatic and biliary tumors. World J Gastrointest Oncol 2022; 14(1): 203-215 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i1/203.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i1.203 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
